Live Breaking News & Updates on Relapsing Remitting Multiple

Stay updated with breaking news from Relapsing remitting multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

West Cumbrian mum: 'Diagnosis of rare form of MS was like a death sentence'


A West Cumbrian mum says being diagnosed with multiple sclerosis was like receiving “a death sentence”.
Brogan Johnston was left shocked and devastated when MRI scans found that she had a form of MS called Relapsing Remitting Multiple Sclerosis.
MS has no cure and is a lifelong condition that affects the nerves, spinal cord, and brain. This happens when the body’s immune system mistakenly attacks a healthy part of the body – in this case, it damages and destroys the fatty substance that coats and protects the nerve fibres called the Myelin Sheath.
When the Myelin Sheath is being damaged by the faulty immune system this is where a relapse occurs, basically meaning anything from loss of vision, loss of mobility, loss of balance, loss of sensation and many, many more devastating outcomes. Once the Myelin Sheath has been damaged so many times that the body cannot repair itself, it then becomes a permanent disabling disease. ....

United Kingdom , Brogan Johnston , Clinica Ruiz , Scott Johnston , West Cumbrian , Relapsing Remitting Multiple , Myelin Sheath , Haematopoietic Stem Cell Transplantation , ஒன்றுபட்டது கிஂக்டம் , கிளினிகா ர்டீஸ் , ஸ்காட் ஜான்ஸ்டன் , மேற்கு கஂப்ரியந் ,

Janssen to Highlight Latest Research on Multiple Sclerosis at ACTRIMS Forum 2021


Janssen to Highlight Latest Research on Multiple Sclerosis at ACTRIMS Forum 2021
News provided by
Share this article
Share this article
TITUSVILLE, N.J., Feb. 24, 2021 /PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that its latest multiple sclerosis (MS) research will be presented at the 2021 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum from February 25-27. Nine Janssen-sponsored data abstracts on MS research will be presented, including real-world evidence highlighting the impact of fatigue in U.S. adults with relapsing MS (RMS); a study assessing the impact of MS fatigue on work productivity and activity impairment; and cross-sectional analyses of both the economic and humanistic burden associated with fatigue in relapsing-remitting MS. ....

United States , Jennifer Mcintyre , Chris Delorefice , Bill Martin , Us National Health , Americas Committee For Treatment , Sclerosis Association Of America , National Multiple Sclerosis Society , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Research In Multiple Sclerosis , None Of The Janssen Pharmaceutical Companies , Drug Administration , Actelion Pharmaceuticals Ltd , Exchange Commission , Companies Of Johnson , Idorsia Pharmaceuticals Ltd , European Medicines Agency , Multiple Sclerosis , Global Therapeutic Area Head , Janssen Research , Data Presentations Include , Fatigue Status , Disease Activity , Fatigue Symptom ,